CAR T Cell Therapy: A Game Changer in Cancer Treatment
Author:
Affiliation:
1. Cellular Medicine, Bioproduction, Thermo Fisher Scientific, 0309 Oslo, Norway
2. Cell Biology, Thermo Fisher Scientific, Frederick, MD 21704, USA
Abstract
Publisher
Hindawi Limited
Subject
Immunology,General Medicine,Immunology and Allergy
Link
http://downloads.hindawi.com/journals/jir/2016/5474602.pdf
Reference122 articles.
1. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.
2. A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer
3. Are All Chimeric Antigen Receptors Created Equal?
4. Sorting Through Subsets
5. Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells
Cited by 124 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Rationally designed approaches to augment CAR-T therapy for solid tumor treatment;Bioactive Materials;2024-03
2. Decoding the mechanisms of chimeric antigen receptor (CAR) T cell-mediated killing of tumors: insights from granzyme and Fas inhibition;Cell Death & Disease;2024-02-02
3. Bacterial immunotherapy: is it a weapon in our arsenal in the fight against cancer?;Frontiers in Immunology;2023-11-27
4. Journey of CAR T‑cells: Emphasising the concepts and advancements in breast cancer (Review);International Journal of Oncology;2023-10-10
5. Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach;Cell Reports Medicine;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3